Trial intelligence / Profile preview

Ketamine versus remifentanil for cardiovascular responses during pediatric tonsillectomy

IRCT20260815070653N1Phase 3Recruiting

Sponsor
Hormozgan University of Medical Sciences
Start
Sep 2026
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Remifentanil group with Ketamine group (2 arms). Primary endpoints: Hemodynamic responses, Pain intensity and 2 more. Started Sep 2026; status: recruiting.

02

Drugs

ketamineremifentanil

Beyond the preview

Go deeper on IRCT20260815070653N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260815070653N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call